YP
AGN

Yellowstone Partners’s Allergan plc AGN Stock Holding History

Yellowstone Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$329K Sell
2,011
-796
-28% -$143K 0.19% 117
2017
Q3 		$575K Buy
+2,807
New +$653K 0.3% 86
2016
Q3 		$1.39M Sell
6,025
-304
-5% -$74.3K 0.51% 50
2016
Q2 		$1.46M Buy
+6,329
New +$1.46M 0.63% 39

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Yellowstone Partners's AGN Position: Q4 2017 in Review

Yellowstone Partners reduced its Allergan plc (AGN) stake by 28% in Q4 2017, selling an estimated $143K and leaving 2,011 shares worth $329K. The position accounts for 0.19% of the portfolio, ranked #117.

Yellowstone Partners first reported a position in AGN in Q2 2016 and has held it in 4 quarters since. The position peaked at $1.46M in Q2 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Yellowstone Partners held 2,011 shares of Allergan plc worth $329K as of Q4 2017.
  • Yellowstone Partners sold 796 Allergan plc shares in Q4 2017, an estimated $143K.
  • Allergan plc made up 0.19% of Yellowstone Partners's portfolio in Q4 2017, its #117 holding.
  • Yellowstone Partners first reported a position in Allergan plc in Q2 2016 and has held it in 4 quarters since.
  • Yellowstone Partners's Allergan plc position peaked at $1.46M in Q2 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.